PHARMASGP HOLDING SE O.N.
PHARMASGP HOLDING SE O.N./ DE000A2P4LJ5 /
PSG
|
15/11/2024 14:41:14
|
Diferencia
+0.60
|
Volumen |
Bid17:36:06 |
Ask17:36:06 |
Capitalización de mecado |
Dividendo A. |
P/E Ratio |
|
26.40EUR
|
+2.33%
|
211
Volumen de negocios: 5,447.40 |
23.60Volumen de oferta: 50 |
25.80Tamaño/ Volumen/ Formato de Ask: 50 |
304.61 millonesEUR |
5.35% |
18.54 |
Descripción de negocio
PharmaSGP is a pure-play consumer health company with a broad portfolio of leading chemical-free non-prescription pharmaceuticals sold over the counter (“OTC”) and other healthcare products. PharmaSGP’s products are sold exclusively through pharmacies. Its products are based on natural active pharmaceutical ingredients with documented efficacy and fewer known side effects than most chemical-based pharmaceuticals. The Company’s core brands cover chronic indications, including pain and other age-related ailments.
Consejo de gestión & Consejo de supervisión
| CEO |
| Natalie Weigand |
| Consejo de gestión |
| Michael Rudolf, Peter Gerckens |
| Consejo de supervisión |
| Dr. Clemens Fischer, Madlena Hohlefelder, Dr. Axel Rebien |
Datos de la empresa
| Nombre: |
PharmaSGP Holding SE |
| Dirección: |
Lochhamer Schlag 21,D-82166 Gräfelfing |
| Teléfono: |
+49-611-2058-5528 |
| Fax: |
+49-611-2058-5566 |
| E-mail: |
info@pharmasgp.com
|
| Internet: |
https://pharmasgp.com/ |
| Industria: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Subsector: |
Pharmaceuticals |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
- |
| Fecha de OPI: |
19/06/2020 |
Relación con inversores
| Nombre: |
Claudius Krause |
| IR teléfono: |
+49-611-2058-5535 |
| IR-fax: |
- |
| IR e-mail: |
ir@pharmasgp.com
|
Calendario de la empresa
|
CW 48 | 28/11/2024
Interim Report 3rd Quarter/9 Months
|
